Kistler-Tiffany Companies’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-690
| Closed | – | – | 650 |
|
|
2020
Q1 | $0 | Hold |
690
| – | – | ﹤0.01% | 576 |
|
|
2019
Q4 | $0 | Hold |
690
| – | – | ﹤0.01% | 603 |
|
|
2019
Q3 | $0 | Hold |
690
| – | – | ﹤0.01% | 609 |
|
|
2019
Q2 | $0 | Hold |
690
| – | – | ﹤0.01% | 599 |
|
|
2019
Q1 | $0 | Hold |
690
| – | – | ﹤0.01% | 588 |
|
|
2018
Q4 | $0 | Hold |
690
| – | – | ﹤0.01% | 585 |
|
|
2018
Q3 | $1K | Hold |
690
| – | – | ﹤0.01% | 552 |
|
|
2018
Q2 | $1K | Hold |
690
| – | – | ﹤0.01% | 560 |
|
|
2018
Q1 | $1K | Hold |
690
| – | – | ﹤0.01% | 550 |
|
|
2017
Q4 | $1K | Hold |
690
| – | – | ﹤0.01% | 548 |
|
|
2017
Q3 | $1K | Hold |
690
| – | – | ﹤0.01% | 541 |
|
|
2017
Q2 | $1K | Hold |
690
| – | – | ﹤0.01% | 500 |
|
|
2017
Q1 | $1K | Hold |
690
| – | – | ﹤0.01% | 500 |
|
|
2016
Q4 | $4K | Hold |
690
| – | – | ﹤0.01% | 463 |
|
|
2016
Q3 | $4K | Hold |
690
| – | – | ﹤0.01% | 489 |
|
|
2016
Q2 | $4K | Sell |
690
-402
| -37% | -$2.33K | ﹤0.01% | 499 |
|
|
2016
Q1 | $5K | Hold |
1,092
| – | – | ﹤0.01% | 468 |
|
|
2015
Q4 | $7K | Buy |
+1,092
| New | +$7K | ﹤0.01% | 476 |
|